Supawat Thongthip
Stock Analyst at Truist Financial
(0.62)
# 4,229
Out of 5,004 analysts
14
Total ratings
35.7%
Success rate
-10.9%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Supawat Thongthip
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AVBP ArriVent BioPharma | Reiterated: Buy | n/a | $28.45 | - | 1 | Sep 15, 2026 | |
| RCUS Arcus Biosciences | Reiterated: Buy | $40 | $24.97 | +60.19% | 5 | Sep 8, 2026 | |
| STRO Sutro Biopharma | Reiterated: Buy | $50 | $15.98 | +212.89% | 3 | Aug 13, 2026 | |
| IMNM Immunome | Reiterated: Buy | $38 | $21.41 | +77.49% | 3 | Aug 12, 2026 | |
| JANX Janux Therapeutics | Reiterated: Buy | n/a | $16.30 | - | 2 | Aug 7, 2026 |
ArriVent BioPharma
Sep 15, 2026
Reiterated: Buy
Price Target: n/a
Current: $28.45
Upside: -
Arcus Biosciences
Sep 8, 2026
Reiterated: Buy
Price Target: $40
Current: $24.97
Upside: +60.19%
Sutro Biopharma
Aug 13, 2026
Reiterated: Buy
Price Target: $50
Current: $15.98
Upside: +212.89%
Immunome
Aug 12, 2026
Reiterated: Buy
Price Target: $38
Current: $21.41
Upside: +77.49%
Janux Therapeutics
Aug 7, 2026
Reiterated: Buy
Price Target: n/a
Current: $16.30
Upside: -